Given the specific requirements of collective invasion for spatial and cancer cell-induced ECM stiffness and the differential responses of ductal and lobular breast cancer cells to inhibition of lysyl oxidases, our finding may present options for the future diagnosis or treatment of specific breast cancer sub-types. This evidence concerns the gene LOX and breast carcinoma.